Pay in 4 interest-free payments of $5.00 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
Meshkat S, Di Luciano C, Swiderski A, Li G, Aguilar RJ, Dunkley BT, Reichelt AC, Zhang Y, Greenshaw A, Vermetten E, Jetly R, Dash S, Agarwal SM, Swainson J, Bhat V (2025) Efficacy and Safety of Glucagon-Like Peptide-1 Agonists for Psychiatric Symptoms: A Systematic Review
Gastrointestinal symptoms should be tracked, as persistent severe nausea, vomiting, or abdominal pain may indicate complications such as pancreatitis or gallbladder disease, which require immediate medical evaluation
Physician-prescribed topical formulations deliver the peptide exactly where the benefits occur, at therapeutic concentrations (2 to 10 percent or more), without systemic distribution
Blum says, "Microdosing a GLP-1 means you're taking a dose that's lower than the lowest granular dose designated for weight loss." A therapeutic dose for weight loss using a semaglutide medication (Wegovy or Ozempic) is typically 2.4 mg, and the therapeutic dose for a tirzepatide medication (Zepbound and Mounjaro) is around 15 mg
Don't underestimate the importance of sleep Poor sleep increases hunger hormones and cravings
Existing findings are largely derived from preclinical and exploratory models, and the mechanistic scope of these observations remains under ongoing investigation
